Finorify

DBD

Diebold Nixdorf

$85.11+0.89%

Price

DBD daily closing price
Market cap
$2.95 billion
P/E (TTM)
28.28
EV/EBITDA
10.51
Volume
140.0K
Sector
Technology

Diebold Nixdorf (DBD) last closed at $85.11, on a daily price path from October 21, 2025 to October 21, 2026. Overview is that price path. Performance is the change in the close over the periods Finorify shows on the stock screen. Financials, cash flow, and margins come from reported quarters. Valuation lists the latest ratios. This snapshot is the Finorify stock screen for DBD, covered for search and blurred for visitors.

Performance

  • 1D+0.47%
  • 5D+6.02%
  • 1M+5.85%
  • 3M-21.64%
  • 6M-19.05%
  • 1Y+18.72%

Financials

DBD revenueQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Over the latest four reported periods ending June 30, 2026, Diebold Nixdorf reported revenue of $3.87 billion.

The prior window totaled $3.67 billion, so the latest window is higher than that stretch.

Operating cash flow in the latest window was $273 million.

Free cash flow in the latest window was $273 million.

These amounts are taken from Diebold Nixdorf's SEC filings and are a snapshot as of August 14, 2026. They are not a live price, and they are not a recommendation to buy or sell. Finorify uses the same filings to draw the charts inside the app.

A few ratios from those statements: Profitability: ROE 1.6% (7 of 100). Leverage: D/E 1.00× (60 of 100). Cash generation: FCF margin 7.1% (14 of 100). Net margin: 1.7% (4 of 100). Liquidity: Current 1.27× (63 of 100).

Cash Flow

DBD free cash flowQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Margins

DBD operating margin

Valuation

P/E (TTM)
28.28
P/S (TTM)
0.76
EV/EBITDA
10.51

Insights

Finorify has not written notes for DBD in this snapshot.

Read the live analysis in Finorify

Charts, news, and the written notes are in the app. You can open five distinct stocks free. After that, the stock screen is a Finorify Pro feature.

Open DBD in Finorify